Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-03-04
2008-03-04
Wessendorf, T. D. (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S005000, C435S004000, C435S091500, C435S091500, C536S023100, C536S001110
Reexamination Certificate
active
07338762
ABSTRACT:
The present invention includes composition and methods for making and using a combinatorial library having two or more beads, wherein attached to each bead is a unique nucleic acid aptamer that have disposed thereon a unique sequence. The library aptamers may be attached covalently to the one or more beads, which may be polystyrene beads. The aptamers may include phosphorothioate, phosphorodithioate and/or methylphosphonate linkages and may be single or double stranded DNA, RNA or even PNAs.
REFERENCES:
patent: 5218088 (1993-06-01), Gorensein
patent: 5270163 (1993-12-01), Gold et al.
patent: 5397698 (1995-03-01), Goodman
patent: 5475096 (1995-12-01), Gold et al.
patent: 5576302 (1996-11-01), Cook
patent: 5582981 (1996-12-01), Toole et al.
patent: 5587361 (1996-12-01), Cook
patent: 5599797 (1997-02-01), Cook
patent: 5602000 (1997-02-01), Hyman
patent: 5607923 (1997-03-01), Cook
patent: 5620963 (1997-04-01), Cook
patent: 5635488 (1997-06-01), Cook
patent: 5639603 (1997-06-01), Dower et al.
patent: 5639873 (1997-06-01), Barascut
patent: 5660985 (1997-08-01), Pieken
patent: 5661134 (1997-08-01), Cook
patent: 5663153 (1997-09-01), Hutcherson et al.
patent: 5668265 (1997-09-01), Nadeau et al.
patent: 5670637 (1997-09-01), Gold et al.
patent: 5696249 (1997-12-01), Gold et al.
patent: 5705337 (1998-01-01), Gold
patent: 5734041 (1998-03-01), Just
patent: 5756291 (1998-05-01), Griffin et al.
patent: 5763595 (1998-06-01), Gold
patent: 5795721 (1998-08-01), Rabin
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5804445 (1998-09-01), Brasier
patent: 5844106 (1998-12-01), Seela et al.
patent: 5853984 (1998-12-01), Davis
patent: 5874219 (1999-02-01), Rava
patent: 6171792 (2001-01-01), Brent et al.
patent: 6180348 (2001-01-01), Li
patent: 6242246 (2001-06-01), Gold
patent: 6346611 (2002-02-01), Pagratis et al.
patent: 6369208 (2002-04-01), Cole et al.
patent: 6423493 (2002-07-01), Gorenstein
patent: 6458543 (2002-10-01), Gold
patent: 6503715 (2003-01-01), Gold
patent: 6514948 (2003-02-01), Raz et al.
patent: 6544776 (2003-04-01), Gold
patent: 6551795 (2003-04-01), Rubenfield et al.
patent: 6610504 (2003-08-01), Yuan
patent: 6713616 (2004-03-01), Pagratis et al.
patent: 6716629 (2004-04-01), Hess et al.
patent: 6867289 (2005-03-01), Gorenstein et al.
patent: 2001/0014461 (2001-08-01), Hutchens et al.
patent: 2001/0014479 (2001-08-01), Hutchens et al.
patent: 2001/0034330 (2001-10-01), Kensil
patent: 2003/0133229 (2003-07-01), Klinman et al.
patent: 2003/0162190 (2003-08-01), Gorenstein et al.
patent: 2003/0162216 (2003-08-01), Gold
patent: 2003/0186906 (2003-10-01), Schlingensiepen et al.
patent: 0 855 184 (1998-07-01), None
patent: WO 92 14842 (1992-09-01), None
patent: WO 92 14843 (1992-09-01), None
patent: WO 93 08296 (1993-04-01), None
patent: 94/01550 (1994-01-01), None
patent: WO 96 19572 (1996-06-01), None
patent: WO 99 31275 (1999-06-01), None
patent: 99/54506 (1999-10-01), None
patent: 00/24404 (2000-05-01), None
patent: WO 00 47774 (2000-08-01), None
patent: WO 96 41019 (2000-08-01), None
patent: 2004/026260 (2004-04-01), None
patent: 2005/003291 (2005-01-01), None
patent: 2005/018357 (2005-03-01), None
patent: 2005/032455 (2005-04-01), None
patent: 2005/037053 (2005-04-01), None
Antsypovich, et al. (1998) Cross-linked DNA duplexes: Exonuclease stability and interaction with the nucleic transcription factor of the κ light chain enhancer (NF-κB).
Bielinska, et al. (1990) Regulation of Gene Expression with Double-Stranded Phosphorothioate Oligonucleotides,Science, vol. 250, p. 997-1000.
Khaled, et al. (1998) Use of Phosphorothioate-Modified Oligodeozynuceotides to inhibit NF-κB Expression and Lymphocyte Function,Clinical Immunology and Immunopathology, vol. 86, No. 2, pp. 170-179.
King, et al., (1998) Novel Combinatorial Selection of Phosphorothioate Oligonucleotide Aptamers.Biochemistry, 37, 16489-16493.
Kunsch, et al. (1992) Selection of Optimal κB/Rel DNA-Binding Motifs: Interaction of Both Subunits of NF-κB with DNA is Required for Transcriptional Activation,Molecular and Cellular Biology, Oct. 1992, vol. 12, No. 10, p. 4412-4421.
Lebruska, et al. (1999) Selection and Characterization of an RNA Decoy for Transcription Factor NF-κB+,Biochemistry, 38, 3168-3174.
Morishita, et al. (1997) In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocarial infarction,Nature Medicine, vol. 3, No. 8, p. 894-899.
Nakamaye, et al. (1988) Direct sequencing of polymerase chain reaction amplified DNA fragments through the incorporation of deoxynucleoside α-thiophosphates,Nucleic Acids Research, vol. 16, No. 21.
Sharma, et al. (1996) Transcription Factor Decoy Approach to Decipher the Role of NF-κB in Oncogenesis,Anticancer Research, 16:61-70.
Stec, et al. (1997) Deoxyribonucleoside 3'-O-(2-Thio- and 2-Oxo-“spiro”-4,4-pentamethylene-1,3,2-oxathiaphospholane)s: Monomers for Stereocontrolled Synthesis of Oligo(deoxyribonucleoside phosphorothioate)s and Chimeric PS/PO Oligonucleotides§,J. Am. Chem. Soc., 120, 7156-7167.
Uhlmann, et al. (1997) Studies of the Mechanism of Stabilization of Partially Phosphorothioated Oligonucleotides Against Nucleolytic Degradation,Antisense&nucleic Acid Drug Development, 7:345-350.
Zon, Gerald (1988) Oligonucleotide Analogues as Potential Chemotherapeutic Agents. Pharmaceutical Research, vol. 5, No. 9, pp. 539-549.
Partial Supplementary European Search Report for Application No. 04776088.9 (PCT/US2004/016246) dated Jun. 29, 2007.
Partial Supplementary European Search Report for Application No. 04809405.6 (PCT/US2004/016061) dated Jul. 3, 2007.
Bane, et al., “DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation,” Nucleic Acids Research (2002), 30:e69.
Dick, et al., “Aptamer-Enhanced Laser Desorption/Ionization of Affinity Mass Spectrometry,” Analytical Chemistry (2004), 76:3037-3041.
Wang, et al., “Identification of Proteins Bound to a Thioaptamer Probe on a Proteomics Array,” Biochemical and Biophysical Research Communications (2006), 347:586-593.
Amarzguioui, M., et al., Nuc Acids Res, 31, 589-595, (2003)— Tolerance for mutations and chemical modifications in a SiRNA.
Andreola, M., et al., “ Towards the Selection of Phosphorothioate Aptamers: Optimizing In Vitro Selection Steps with Phosphorothioate Nucleotides,” European Journal of Biochemistry 267:5032-5040.
Braasch, D.A., et al., Nucleic Acids Res, 30(23), 5160-7 (2002)—Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.
Braasch, D.A. and D.R. Corey, Biochemistry, 41, 4503-4510 (2002)—Novel anitsense and peptide nucleic acid strategies for controlling gene expression.
Caplen, N.J., et al., PNAS, 98, 9742-9747 (2001)—Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.
Cassiday, L., et al., “In Vivo Recognition of an RNA Aptamer by its Transcription Factor Target,” Biochemistry (2001), 40:2433-3438.
Chi, J.T., PNAS,100(11), 6343-6 (2003)—Genomewide view of gene silencing by small interfering RNAs.
Doucette, et al., Proteomics (2001), 1:987-1000, Investigation of the Applicability of a Sequential Digestion Protocol Using Trypsin and Leucine Aminopeptidase M for Protein Identification by Matrix-Assisted Laser Desorption/Ionization—Time of Flight Mass Spectrometry.
Elbashir, et al., “RNA Interference is Mediated by 21- 22- nucleotide RNAs,” Genes and Development (2001), 15:188-200.
Elbashir, et al., “Functional Anatomy of SiRNAs for Mediating Efficient RNA1 inDrosophilia melanogasterEmbryo Lysate,” EMBO Journal (2001), 20:6877-6888.
Elgemeie, “Thioguanine Mercaptoputine: Their Analogs and Nucleosides as antimetabolites,” Current Pharmaceutical Design (2003), 9:2627-2642.
Fire, et al., Nature, 391, 806 (1998)—Potent and sp
Gorenstein David G.
Herzog Norbert
Luxon Bruce A.
Yang Xianbin
Board of Regents , The University of Texas System
Chalker Flores LLP
Flores Edwin
Wessendorf T. D.
LandOfFree
Bead bound combinatorial oligonucleoside phosphorothioate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bead bound combinatorial oligonucleoside phosphorothioate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bead bound combinatorial oligonucleoside phosphorothioate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2787422